BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28581463)

  • 1. The burden of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning: a prospective study.
    Flank J; Sparavalo J; Vol H; Hagen L; Stuhler R; Chong D; Courtney S; Doyle JJ; Gassas A; Schechter T; Dupuis LL
    Bone Marrow Transplant; 2017 Sep; 52(9):1294-1299. PubMed ID: 28581463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor chemotherapy-induced nausea and vomiting control in children receiving intermediate or high dose methotrexate.
    Vol H; Flank J; Lavoratore SR; Nathan PC; Taylor T; Zelunka E; Maloney AM; Lee Dupuis L
    Support Care Cancer; 2016 Mar; 24(3):1365-71. PubMed ID: 26335406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study.
    López-Jiménez J; Martín-Ballesteros E; Sureda A; Uralburu C; Lorenzo I; del Campo R; Fernández C; Calbacho M; García-Belmonte D; Fernández G
    Haematologica; 2006 Jan; 91(1):84-91. PubMed ID: 16434375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced nausea and vomiting control in pediatric patients receiving ifosfamide plus etoposide: a prospective, observational study.
    Patel P; Lavoratore SR; Flank J; Kemp M; Vennettilli A; Vol H; Taylor T; Zelunka E; Maloney AM; Nathan PC; Dupuis LL
    Support Care Cancer; 2020 Feb; 28(2):933-938. PubMed ID: 31177392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed chemotherapy-induced nausea and vomiting in autologous hematopoietic cell transplant patients: an exploratory analysis.
    Gonella S; Di Giulio P
    Tumori; 2015 Nov; 101(6):e154-9. PubMed ID: 26045114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nausea and vomiting in children and adolescents receiving intrathecal methotrexate: A prospective, observational study.
    Flank J; Nadeem K; Moledina S; Khanna M; Schindera C; Punnett A; Dupuis LL
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28500750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes.
    Liau CT; Chu NM; Liu HE; Deuson R; Lien J; Chen JS
    Support Care Cancer; 2005 May; 13(5):277-86. PubMed ID: 15770489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
    Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
    J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation.
    Kusnierczyk NM; Saunders EF; Dupuis LL
    Bone Marrow Transplant; 2002 Jul; 30(2):119-24. PubMed ID: 12132051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.
    Grunberg SM; Deuson RR; Mavros P; Geling O; Hansen M; Cruciani G; Daniele B; De Pouvourville G; Rubenstein EB; Daugaard G
    Cancer; 2004 May; 100(10):2261-8. PubMed ID: 15139073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.
    Tamura K; Aiba K; Saeki T; Nakanishi Y; Kamura T; Baba H; Yoshida K; Yamamoto N; Kitagawa Y; Maehara Y; Shimokawa M; Hirata K; Kitajima M;
    Int J Clin Oncol; 2015 Oct; 20(5):855-65. PubMed ID: 25681876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed.
    Erazo Valle A; Wisniewski T; Figueroa Vadillo JI; Burke TA; Martinez Corona R
    Curr Med Res Opin; 2006 Dec; 22(12):2403-10. PubMed ID: 17257454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
    Baba Y; Baba H; Yamamoto S; Shimada H; Shibata T; Miyazaki T; Yoshikawa T; Nakajima Y; Tsuji Y; Shimokawa M; Kitagawa Y; Aiba K
    Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27001532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed nausea and vomiting in children receiving antineoplastics.
    Dupuis LL; Lau R; Greenberg ML
    Med Pediatr Oncol; 2001 Aug; 37(2):115-21. PubMed ID: 11496349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life.
    Abunahlah N; Sancar M; Dane F; Özyavuz MK
    Int J Clin Pharm; 2016 Dec; 38(6):1464-1476. PubMed ID: 27796777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review.
    Polito S; MacDonald T; Romanick M; Jupp J; Wiernikowski J; Vennettilli A; Khanna M; Patel P; Ning W; Sung L; Dupuis LL
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27374. PubMed ID: 30051617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective observational study on chemotherapy-induced nausea and vomiting (CINV) in patients with gynecologic cancer by the CINV Study Group of Japan.
    Mizuno M; Hiura M; Kikkawa F; Numa F; Yaegashi N; Narahara H; Aoki D; Kimura E; Kato H; Shimokawa M; Sugiyama T; Kamura T
    Gynecol Oncol; 2016 Mar; 140(3):559-64. PubMed ID: 26748216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM
    J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting.
    Ng T; Mazzarello S; Wang Z; Hutton B; Dranitsaris G; Vandermeer L; Smith S; Clemons M
    Breast Cancer Res Treat; 2016 Jan; 155(2):337-44. PubMed ID: 26732944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of chemotherapy-induced nausea and vomiting in Italy.
    Ballatori E; Roila F; Ruggeri B; Porrozzi S; Iannopollo M; Soru G; Cruciani G; Daniele B; Locatelli MC; Pellissier J; Deuson R
    Support Care Cancer; 2007 Jan; 15(1):31-8. PubMed ID: 16788840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.